Your session is about to expire
← Back to Search
Antibiotics for Preventing Infections After Pancreatic Surgery
Study Summary
This trial will compare two different antibiotics to see which one is better at preventing surgical site infections after pancreatoduodenectomy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 2 & 3 trial • 465 Patients • NCT02753946Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am having or had a minimally invasive surgery for pancreatic disease.My kidney function is low, with a creatinine clearance of 40 mL/min or less.I have an infection or took antibiotics within a week before surgery.You cannot receive the antibiotics used in this study for other reasons.You are allergic to penicillins, cephalosporins, or β-lactamase inhibitors.I am 18 years old or older.I am scheduled for a surgery to remove part of my pancreas and small intestine.I am currently on dialysis.I am unable to understand and give consent for treatment.My surgeon believes my pancreatic condition can be treated without removing the pancreas.I use steroids only in specific ways, like creams, inhalers, or eye drops.
- Group 1: Piperacillin-tazobactam
- Group 2: Cefoxitin
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the total participant count for this clinical trial?
"Presently, this study is not looking for new participants. It was first posted on November 21st, 2017 and was last edited on August 31st, 2022. If you are hoping to find other studies, 734 clinical trials are actively recruiting patients with pancreatic diseases and 19 studies are enrolling patients that Piperacillin-tazobactam."
Could you elaborate on other scientific research that has used Piperacillin-tazobactam?
"59 clinical trials have completed studying piperacillin-tazobactam since it was first examined in 2016 at Milton Keynes University Hospital. Out of the 19 trials currently underway, a large proportion are located in Philadelphia, Pennsylvania."
Are there a large number of facilities conducting this particular clinical trial across the state?
"Some of the hospitals currently running this trial are Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, Ohio State University in Columbus, Ohio, and UC Davis Comprehensive Cancer Center in Sacramento, California - to name a few of the 31 other locations."
When is Piperacillin-tazobactam typically given to patients?
"Piperacillin-tazobactam is commonly used to fight intraabdominal infections. This medication can also help patients with lower respiratory tract infection (lrti), lung abscess, and bacterial infections."
Are new participants currently being welcomed into this research?
"According to the website, this clinical trial is not recruiting patients at the moment. The original posting date was November 21st, 2017, and the most recent edit was on August 31st, 2022. There are, however, 753 other trials that are actively recruiting patients."
If I take Piperacillin-tazobactam, are there any risks I should be aware of?
"We believe that Piperacillin-tazobactam is safe based on the fact that it is a Phase 3 trial, which suggests that there is both efficacy and safety data supporting its use."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger